Quantcast
Last updated on April 17, 2014 at 16:43 EDT

Latest Drug delivery Stories

2013-07-25 23:21:11

“Drug Delivery Technologies Market” research reports available for Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants, Novel Product and Formulation Technology at ReportsnReports.com store. Dallas, Texas (PRWEB) July 25, 2013 The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9%...

2013-07-25 12:28:19

NEW YORK, July 25, 2013 /PRNewswire/ -- Alliqua, Inc. (OTCQB: ALQA), a wound management and drug delivery company, is making strides to take advantage of the $142 billion drug delivery market by launching a preclinical proof-of-principal study of an experimental hydrogel transdermal patch containing lidocaine. The global drug delivery market is expected to reach $224.2 billion by the year 2017. Additionally, the global wound dressing market is expected to reach $6 billion by...

2013-07-23 23:18:19

This research report categorizes the North American drug delivery technologies market by routes of administration; it includes oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal technologies. (PRWEB) July 23, 2013 The “North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular...

2013-07-15 23:21:59

As diabetes rates reach alarming rates in the United States, affecting close to 10% of the total population, the market for diagnostics and treatment of the illness grows. Vancouver, Canada (PRWEB) July 15, 2013 According to the latest statistics recorded by the American Diabetes Association, over 25 million children and adults in the United States were suffering from diabetes in 2011. Moreover, it is estimated that there are 79 million people who are prediabetic. People with prediabetes...

2013-07-11 08:28:44

The growing challenge of medication adherence has significant health and financial implications MOUNTAIN VIEW, Calif., July 11, 2013 /PRNewswire/ -- The $82 billion U.S. drug delivery market is showing no signs of saturation, with major patent expiries, generic competition, tightening Food and Drug Administration (FDA) regulations, and emerging drug delivery systems continuing to provide momentum. Among the 15 drug delivery systems surveyed by Frost & Sullivan, physicians prefer...

2013-07-10 15:59:10

Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate and expand in the presence of higher acidity found in tumor cells. The concept involves using nanoparticles made of "weak polybases," compounds that expand when transported into environments mimicking tumor cells, which have a higher acidity than surrounding tissues. The researchers used sophisticated modeling to show how the particles would accumulate in...

2013-07-09 08:28:03

DALLAS, July 9, 2013 /PRNewswire/ -- The "North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) Forecasts to 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America. Browse - 95 Market Data Tables - 28 Figures - 267...

2013-07-04 23:01:12

Research report “Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies” created by MP Advisors has been recently published by Market Publishers Ltd. According to the study, revenues within the worldwide generics market were worth around USD 265 billion in 2012. London, UK (PRWEB) July 04, 2013 In 2012, revenues within the worldwide generics market were worth around USD 265 billion, registering growth by...

2013-07-02 08:26:44

West's NovaGuard systems help keep healthcare workers and patients safe from needlestick injuries EXTON, Pa., July 2, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products. The NovaGuard SA (Staked-needle Automatic) system, formerly called the B.Safe syringe system technology, is now part...

2013-07-02 08:25:32

DALLAS, July 2, 2013 /PRNewswire/ -- The report "European Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE)....